Critical review of the role of HTS in drug discovery

被引：160

作者：

Macarron, R ^{[1
]}

机构：

[1] GlaxoSmithKline Inc, Collegeville, PA 19426 USA

来源：

DRUG DISCOVERY TODAY | 2006年 / 11卷 / 7-8期

关键词：

D O I：

10.1016/j.drudis.2006.02.001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：277 / 279

页数：3

共 20 条

[11] The druggable genome [J].

Hopkins, AL ;

Groom, CR .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (09) :727-730

[12]

LANDERS P, 2004, WALL STREET J 0224

[13] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].

Lipinski, CA ;

Lombardo, F ;

Dominy, BW ;

Feeney, PJ .

ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25

[14]

MOORE SD, 1995, WALL STREET J 1020

[15] Design of signal windows in high throughput screening assays for drug discovery [J].

Sittampalam, GS ;

Iversen, PW ;

Boadt, JA ;

Kahl, SD ;

Bright, S ;

Zock, JM ;

Janzen, WP ;

Lister, MD .

JOURNAL OF BIOMOLECULAR SCREENING, 1997, 2 (03) :159-169

[16]

Spencer RW, 1998, BIOTECHNOL BIOENG, V61, P61, DOI 10.1002/(SICI)1097-0290(199824)61:1<61::AID-BIT11>3.0.CO

[17]

2-C

[18] A standard operating procedure for assessing liquid handler performance in high-throughput screening [J].

Taylor, PB ;

Ashman, S ;

Baddeley, SM ;

Bartram, SL ;

Battle, CD ;

Bond, BC ;

Clements, YM ;

Gaul, NJ ;

McAllister, WE ;

Mostacero, JA ;

Ramon, F ;

Wilson, JM ;

Hertzberg, RP ;

Pope, AJ ;

Macarron, R .

JOURNAL OF BIOMOLECULAR SCREENING, 2002, 7 (06) :554-569

[19] Diversity screening versus focussed screening in drug discovery [J].

Valler, MJ ;

Green, D .

DRUG DISCOVERY TODAY, 2000, 5 (07) :286-293

[20] High-throughput screening for kinase inhibitors [J].

von Ahsen, O ;

Bömer, U .

CHEMBIOCHEM, 2005, 6 (03) :481-490

← 1 2 →